Cleared Traditional

K854233 - CMI 3000

K854233 is an FDA 510(k) clearance for CMI 3000, manufactured by Cardio Management, Inc.. The device is a Class 2 Cardiovascular device with product code DRO cleared through the Traditional 510(k) pathway after a 79-day FDA review.

K854233 · Cardio Management, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1986
Decision
79d
Days
Class 2
Risk

K854233 is an FDA 510(k) clearance for the CMI 3000. Classified as Pacemaker, Cardiac, External Transcutaneous (non-invasive) (product code DRO), Class II - Special Controls.

Submitted by Cardio Management, Inc. (Birmingham, US). The FDA issued a Cleared decision on January 8, 1986 after a review of 79 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5550 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cardio Management, Inc. devices

FDA 510(k) Submission Details - K854233

510(k) Number K854233 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 21, 1985
Decision Date January 08, 1986
Days to Decision 79 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 125d · This submission: 79d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRO Device Classification - Class 2, Special Controls

Product Code DRO Pacemaker, Cardiac, External Transcutaneous (non-invasive)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRO Pacemaker, Cardiac, External Transcutaneous (non-invasive)

All 57
Devices cleared under the same product code (DRO) and FDA review panel - the closest regulatory comparables to K854233.
ALTERNATE SIZE E-Z-PACE ELECTRODE
K862298 · Medtronic Vascular · Jul 1986
AMI CARDIO-PAD
K860283 · Andover Medical, Inc. · Mar 1986
AMENDMENT LIFEPAK 8, NPN 052
K854117 · Physio-Control Corp. · Jan 1986
LIFEPAK 8 MODIFICATION
K853732 · Physio-Control Corp. · Dec 1985
EMERGIPACE - EXTERNAL PACEMAKER
K850812 · Life Science Instrumentation, Inc. · Nov 1985
PACEPAC
K852958 · Medical Data Electronics · Oct 1985